POLA PERESEPAN TERAPI ANTIDIABETES ORAL DI PUSKESMAS IMOGIRI BATUL
DOI:
https://doi.org/10.32734/idjpcr.v8i01.20061Keywords:
Type II DM, description of prescribing, drug clas, puskesmasAbstract
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action or both. The prevalence of diabetes mellitus in Indonesia continues to increase and is included in the top 10 diseases at the health center in Bantul Regency. In addition, diabetes mellitus is also included in the top 5 diseases at the Imogiri I Health Center. The purpose of this study was to find out the description of type II diabetes mellitus drug prescription at the Imogiri I Health Center for the period August - December 2022. This study used a non-experimental descriptive method by collecting retrospective medical records of patients with diabetes mellitus type II. The data obtained were then analyzed in a quantitative descriptive manner presented with percentages in the form of diagrams. The results showed that most patients with type II diabetes mellitus were female (31%) with the most age range being 46-65 years (57%). The description of drug prescribing for type II diabetes mellitus patients at the Imogiri I Health Center consists of the use of diabetes mellitus drugs alone, namely the biguanid group (Metformin) as much as 95% and the sulfonylurea group (Glimepirid) as much as 5%. It can be concluded that the drug most often prescribed to patients with diabetes mellitus type II at the Imogiri I Public Health Center with a single treatment is metformin as much as 95% which belongs to the biguanide group.
Downloads
References
PERKENI. 2021. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. PB Perkeni.
IDF (International Diabetes Federation). 2019. IDF Diabetes Atlas Ninth edition 2019. International Diabetes Federation.
Badan Penelitian dan Pengembangan Kesehatan. 2013. Riset Kesehatan Dasar (RISKESDAS) 2013. 1–303.
Badan Penelitian dan Pengembangan Kesehatan. 2018. Riset Kesehatan Dasar (RISKESDAS) 2018. 1–220.
Dinas Kesehatan Kota Yogyakarta. 2020. Profil Kesehatan Tahun 2020 Kota Yogyakarta (Data Tahun 2019).
Dinas Kesehatan Kabupaten Bantul. 2022. Profil Kesehatan Kabupaten Bantul Tahun 2020 (Data Tahun 2019).
Ramadhan, A.M., Rijai, L., Liu, J.M. 2015. Kajian Penggunaan Obat Hipoglikemik Oral pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Temindung Samarinda. Jurnal Sains dan Kesehatan, 1(3): 105–110.
Sappo, N.B., Rahmawati, D., Ramadhan, A.M. 2017. Karakteristik dan Pola Penggunaan Obat Antidiabetik pada Pasien Diabetes Melitus Tipe 2 di RSUD Abdul Wahab Sjarahranie. Mulawarman Pharmaceutical Conference, 41–47.
Suhailis, Syaifiyatul, H., Uswatun, N. 2021. Pola Pengobatan Obat Antidiabetes pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Pegantenan. Archives Pharmacia, 3(1): 24–40.
Rita, N. 2018. Hubungan Jenis Kelamin Olahraga dan Obesitas dengan Kejadian Diabetes Mellitus pada Lansia. Jurnal Ilmu Kesehatan, 2(1): 93–100.
Kabosu, R.A.S., Adu, A.A., Hinga, I.A.T. 2019. Faktor Risiko Kejadian Diabetes Melitus Tipe Dua di RS Bhayangkara Kota Kupang. Timorese Journal of Public Health, 1(1): 12–23.
Imelda, S. 2019. Faktor-faktor yang Mempengaruhi Terjadinya Diabetes Mellitus di Puskesmas Harapan Raya Tahun 2018. SCIENTIA JOURNAL, 8(1): 28–39.
Susilawati, Rahmawati, R. 2021. Hubungan Usia, Jenis Kelamin, dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok. ARKESMAS, 6(1): 15–22.
Pratama, P.Y., Ratnasari, P.M.D. 2021. Pola Penggunaan pada Pasien Diabetes Melitus Tipe II dengan Komplikasi Neuropati pada Salah Satu Rumah Sakit Swasta di Denpasar Bali. Acta Holistica Pharmaciana, 3(2): 30–37.
Hastuti, D., Widhiana, E. 2017. Gambaran Pola Pengobatan Pasien Diabetes Melitus Tipe II di Instalasi Rawat Jalan Puskesmas Mlati II Sleman Yogyakarta Periode Oktober – Desember 2016. AKFARINDO, 2(2): 9–13.
Permana, M. 2018. Internal Medicine Updates: Diabetes pada Lanjut Usia. (Asumsi referensi ini perlu dilengkapi jika disebut dalam teks)
Isnaini, N., Ratnasari. 2018. Faktor Risiko Mempengaruhi Kejadian Diabetes Mellitus Tipe Dua. Jurnal Keperawatan dan Kebidanan Aisyiyah, 14(1): 59–68.
Fanani, A. 2020. Hubungan Faktor Risiko dengan Kejadian Diabetes Mellitus. Jurnal Keperawatan, 12(3): 371–378.
Fikry, A., Aliya, L.S. 2019. Pola Terapi pada Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Inap RSUD Dr. H. Moch. Ansari Saleh, Banjarmasin. Sainstech Farma, 12(1): 54–59.
Suyudi, R.Y., Anggraeni, R., Tanjung, N. 2022. Evaluasi Penggunaan Antidiabetes Pasien DM Tipe II di Puskesmas Sei Kepayang Barat Kabupaten Asahan. Jurnal Farmasi, 5(1): 87–91.
Widiasari, K.R., Wijaya, M.K., Suputra, P.A. 2021. Diabetes Mellitus Tipe 2: Faktor Risiko, Diagnosis, dan Tatalaksana. Ganesha Medicina Journal, 1(2): 114–120.
Ketzung, B.G. 2019. Basic & Clinical Pharmacology (14th Ed.), hlm. 759–761.
Decroli, E. 2019. Diabetes Mellitus Tipe 2. Padang: Pusat Penerbitan Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas.
Hardianto, D. 2020. Telaah Komprehensif Diabetes Mellitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, dan Pengobatan. Jurnal Bioteknologi & Biosains Indonesia, 7(2): 304–317.
Malinda, H., Rahmawati, Hendra, H. 2015. Gambaran Penggunaan Obat Antidiabetik pada Pengobatan Pasien Diabetes Melitus Tipe II Rawat Jalan Di RSUP Dr. Wahidin Sudirohusodo Makassar. As-Syifaa, 7(01): 93–102.
Maulidya, N. 2021. Profil Penggunaan Obat Antidiabetes Oral pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Grabag. Skripsi. Universitas Ngudi Waluyo.
Bintari, T.I. 2021. Gambaran Penggunaan Antidiabetes Oral pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Dharmarini Temanggung. Universitas Magelang.
Artini, K.S., Ajeng, T., Saifana, C.S. 2022. Gambaran Penggunaan Antidiabetes Oral pada Pasien Diabetes Mellitus Tipe 2: Literatur Review. Prosiding Seminar Informasi Kesehatan Nasional (SIKesNas), hlm. 333–340.
Sugiyono. 2019. Metode Penelitian Kuantitatif Kualitatif dan R&D. Bandung: Alfabeta. hlm. 126–127.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Pharmaceutical and Clinical Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) and Faculty of Pharmacy as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR).
The Copyright Transfer Form can be downloaded here.
The copyright form should be signed originally and sent to the Editorial Office in the form of original mail or scanned document.
